4-methylumbelliferone sensitizes breast cancer spheroids to chemotherapeutic treatment with epirubicin: new perspectives for pharmacological repositioning
Impact of Thyroid Hormones on Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells via Integrin αvβ3
4HER project: Impact of HER Family Co-Amplifications on Trastuzumab Efficacy and Clinical Outcomes in HER2-Positive Breast Cancer
Mifepristone treatment reverts T cell exclusion and immunotherapy resistance programs in hormone-dependent breast luminal tumors
Soluble TNF blockade boosts the antitumoral effects of trastuzumab deruxtecan in HER2 positive breast cancer
Differential expression of regulatory T cells marker genes from peripheral blood of breast cancer patients
Relevance of the correct activation of key mitotic proteins for the survival of cells harboring deficient expression of the BRCA1 and BRCA2 tumor suppressors
LINS01 HISTAMINE H3 RECEPTOR ANTAGONISTS OVERCOME PLACLITAXEL CHEMORESISTANCE IN 4T1 TRIPLE NEGATIVE BREAST CANCER
Extracellular vesicles derived from TNF-α conditioned macrophages promote endocrine resistance in breast tumor cells
